1. Case Report of Thymoma Tumor Reduction Following Plasmapheresis. Issue 47 (November 2015) Authors: Jiang, Wei; Yu, Qitao Other Names: Salama. Joseph section editor. Journal: Medicine Issue: Volume 94:Issue 47(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Case Report of Thymoma Tumor Reduction Following Plasmapheresis. Issue 47 (November 2015) Authors: Jiang, Wei; Yu, Qitao Editors: Salama., Joseph Journal: Medicine Issue: Volume 94:Issue 47(2015) Page Start: e2173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study). Issue 12 (21st December 2021) Authors: Yang, Yunpeng; Zhou, Ting; Chen, Xiaozhong; Li, Jingao; Pan, Jianji; He, Xiaohui; Lin, Lizhu; Shi, Ying-rui; Feng, Weineng; Xiong, Jianping; Yang, Kunyu; Yu, Qitao; Zhang, Qunling; Hu, Desheng; Sun, Yan; Hu, Guangyuan; Li, Ping; Shen, Liangfang; Lin, Qin; Zhang, Ben Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study. Issue 8 (August 2021) Authors: Shi, Yuankai; Hu, Xingsheng; Zhang, Shucai; Lv, Dongqing; Wu, Lin; Yu, Qitao; Zhang, Yiping; Liu, Li; Wang, Xiang; Cheng, Ying; Ma, Zhiyong; Niu, Hongrui; Wang, Dong; Feng, Jifeng; Huang, Cheng; Liu, Chunling; Zhao, Hui; Li, Jingzhang; Zhang, Xiaodong; Jiang, Yong Journal: Lancet Issue: Volume 9:Issue 8(2021) Page Start: 829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study. (September 2022) Authors: Zhang, Li; Wang, Zhehai; Fang, Jian; Yu, Qitao; Han, Baohui; Cang, Shundong; Chen, Gongyan; Mei, Xiaodong; Yang, Zhixiong; Stefaniak, Victoria; Lin, Yong; Wang, Shuyan; Zhang, Wen; Sun, Luyao; Yang, Yunpeng Journal: Lung cancer Issue: Volume 171(2022) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Predictive value of pretreatment albumin‐to‐alkaline phosphatase ratio for overall survival for patients with advanced non‐small cell lung cancer. (21st July 2020) Authors: Zhou, Shaozhang; Jiang, Wei; Wang, Huilin; Wei, Ni; Yu, Qitao Journal: Cancer medicine Issue: Volume 9:Number 17(2020) Page Start: 6268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The predictive value of pretreatment haemoglobin-to-red cell distribution width ratio for overall survival of patients with advanced non-small cell lung cancer: a propensity score matching analysis. Issue 4 (April 2021) Authors: Jiang*, Huiqin; Jiang*, Wei; Tan, Liping; Yu, Qitao; Liu, Feiwen; Huang, Yucong; He, Jianbo; Zhou, Shaozhang Journal: Journal of international medical research Issue: Volume 49:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗